• Corpus ID: 3040642

Update: treatment of cryptosporidiosis in patients with acquired immunodeficiency syndrome (AIDS).

  title={Update: treatment of cryptosporidiosis in patients with acquired immunodeficiency syndrome (AIDS).},
  journal={MMWR. Morbidity and mortality weekly report},
  volume={33 9},
  • Published 1984
  • Medicine
  • MMWR. Morbidity and mortality weekly report
In November 1982, 21 patients with acquired immunodeficiency syndrome (AIDS) and severe, protracted diarrhea caused by cryptosporidiosis were reported; the report concluded that no effective treatment for cryptosporidiosis was known at that time ( 1). Since then, 91 additional AIDS patients with chronic cryptosporidiosis have been reported to CDC. Although no therapy has been consistently effective in treating them, preliminary reports suggest that a few may have responded to treatment with… 

Tables from this paper

Multiple drug regimen for severe diarrhea associated with Cryptosporidium in AIDS patients.

The medication was well-tolerated and no significant side-effects were observed and this therapy may therefore be useful in treating cryptosporidiosis in AIDS patients but it requires further evaluation.

Unusual low-grade cryptosporidial enteritis in AIDS: A case report

An unusual case of mild cryptosporidial enteritis which occurred in a male bisexual with AIDS is presented: it is the first time that cryptosporaidiosis has been described in an immunodeficient patient in this country.

Spiramycin in the Treatment of Cryptosporidiosis

Although response to spiramycin has appeared promising, there have been several reported cases of treatment failure, and further investigation with the agent is advocated to determine its role in the treatment of cryptosporidiosis.

Cryptosporidium species, a protean protozoan

From incidental finding, veterinary disease, zoonosis, and opportunistic infection, Cryptosporidium species is now acknowledged as a cause of human diarrheal disease worldwide (30).

A guide to the investigation and treatment of patients with AIDS and AIDS-related disorders.

The acquired immune deficiency syndrome was first described in the United States in 1981, when cases of Pneumocystis carinii pneumonia and Kaposi's sarcoma were reported in previously well homosexual men in Los Angeles and New York.

Low prevalence of intestinal cryptosporidiosis among immunocompetent and immunocompromised patients with and without diarrhoea in Southern Germany

It is concluded that sporadic intestinal cryptosporidiosis in Southern Germany is a rare disease in humans even of younger age, but should be included in the differential diagnosis of diarrhoea in Immunocompetent and immunocompromised patients.

An update on the acquired immunodeficiency syndrome (AIDS)

The wide spectrum of gastrointestinal tract manifestations seen in this pandemic, acquired immunodeficiency syndrome are described, with particular attention to the epidemiology, etiology, and measurement of these problems.


DATA SYNTHESIS: Intestinal cryptosporidiosis in patientswith AIDS can be a life-threatening opportunistic infection. However,there can be significant variability in disease expression,including

Persistent cryptosporidiosis in horses with severe combined immunodeficiency

Since foals with severe combined immunodeficiency lack functional T and B lymphocytes and are incapable of antigen-specific immune responses, they are well suited for evaluating the pathogenesis and treatment of persistent cryptosporidiosis.

Cryptosporidium spp., a frequent cause of diarrhea in Liberian children

The general belief that cryptosporidiosis is primarily a zoonosis is questioned in this study, partly because many carriers and asymptomatic household contacts were found.



Congenital toxoplasmosis. A prospective study of 378 pregnancies.

Treatment with spiramycin during pregnancy reduced the overall frequency of the fetal infections but not of overt disease, and Mothers with antibodies before they became pregnant had no infected infants.

Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage.

The possible use of spiramycin for prevention of relapses in acute Otitis media and in treatment of serous otitis media is discussed, as well as the possibly use of the drug in gonococcal and meningococcal nasopharyngeal carriage.

A comparative study of some combined treatment regimens in acute toxoplasmosis in mice.

Pyrimethamine + sulfamethoxypyridazine was the most effective combination against acute toxoplasmosis in mice.

Spiramycin; clinical and laboratory studies.

This report concerns laboratory studies and a clinical trial with spiramycin in 29 adult patients with bacterial pneumonia and a mixture of three chemical compounds, which can be separated but have not yet been completely differentiated.

Evaluation of spiramycin in meningococcal carriage.

In carriers where spiramycin saliva concentrations reached or surpassed the MIC value of respective strain for 42 h or more meningococci were eliminated from the nasopharynx and throat in approximately 50% of the carriers with all dose schedules.

Antibiotic-associated colitis: always pseudomembranous?

Among the 14 cases of antibiotic-induced colitis, endoscopic features were: in 9 cases typical pseudomembranes, in 4 cases petechiae or ecchymosis or suggillation-like redness with near-to-normal

Bronchial asthma and dermatitis due to spiramycin in a chick breeder

A case of bronchial asthma and dermatitis due to spiramycin is described in a non‐atopic woman who worked as a chick breeder and handling poultry feed containing antibiotic or chemoterapic drugs

Allergic contact dermatitis in veterinary surgeons

Thirty‐six of 37 veterinary surgeons with incapacitating dermatitis had allergic contact dermatitis, mainly from antibiotics such as spiramycin, Penethamate BP and tylosin. Eight were sensitive to

Cancer and industrial chemical production.